Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT-CKD
NCT04708587Recruiting
- Sponsor
- Yonsei University
- Start
- Mar 2021
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin, clopidogrel and prasugrel in coronary artery disease (CAD) (2 arms), sponsored by Yonsei University. Primary endpoint: Net Clinical Adverse Event at 1 year. Started Mar 2021; status: recruiting.
02
Drugs
aspirinclopidogrelprasugrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04708587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04708587.